You are here

Article Text

Article menu
Download PDFPDF
A difficult case
Paroxysmal dysarthria-ataxia syndrome
  1. Marija Cauchi1,
  2. Janice Abela2,
  3. Nicola Dingli1,
  4. Norbert Vella1
  1. 1 Department of Neurosciences, Mater Dei Hospital, Msida, Malta
  2. 2 Department of Medicine, Mater Dei Hospital, Msida, Malta
  1. Correspondence to Dr Marija Cauchi, Mater Dei Hospital, Department of Neurosciences, Msida, Malta; marija.cauchi{at}gov.mt

Abstract

Paroxysmal dysarthria ataxia syndrome presents with recurrent, brief, stereotyped events of dysarthria, limb clumsiness, unsteady gait and vertigo or dizziness that can occur in association with lesions in the midbrain. We describe a case of a woman presenting with paroxysmal dysarthria and ataxia secondary to a midbrain lesion, treated successfully with carbamazepine.

  • CLINICAL NEUROLOGY
  • CEREBELLAR ATAXIA
  • SPEECH

Data availability statement

Data are available in a public, open access repository.

https://doi.org/10.1136/pn-2023-004023

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Data availability statement

    Data are available in a public, open access repository.

    View Full Text

    Footnotes

    • Contributors MC and JA were involved in the management of the case and drafted the manuscript. ND and NV were involved in management of the case and revisions of the case report.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally reviewed by Waqar Rashid, London, UK.

    • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

    Other content recommended for you